Kiyoshi Arai Selected Research

Kiyoshi Arai Research Topics

3	Hypertension (High Blood Pressure) 11/2020 - 12/2015
3	Proteinuria 01/2016 - 03/2012
2	Fibrosis (Cirrhosis) 01/2016 - 12/2015
2	Hypertrophy 01/2016 - 12/2015
2	Insulin Resistance 08/2012 - 03/2009
1	Albuminuria 11/2020
1	Type 2 Diabetes Mellitus (MODY) 11/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2020
1	Inflammation (Inflammations) 01/2016
1	Hyperkalemia 12/2015
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2015
1	Ankylosis 02/2015
1	Root Resorption 02/2015
1	Glucose Intolerance 08/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2012
1	Cardio-Renal Syndrome 03/2012
1	Myocardial Infarction 03/2012

3	esaxerenoneIBA 11/2020 - 12/2015
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 11/2020 - 03/2012
2	Glucose (Dextrose)FDA LinkGeneric 08/2012 - 03/2009
2	Spironolactone (Aldactone)FDA LinkGeneric 08/2012 - 03/2012
1	Antihypertensive Agents (Antihypertensives)IBA 11/2020
1	CreatinineIBA 11/2020
1	AlbuminsIBA 11/2020
1	Angiotensin Receptor AntagonistsIBA 11/2020
1	olmesartanIBA 11/2020
1	Messenger RNA (mRNA)IBA 01/2016
1	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2016
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2015
1	Mineralocorticoid Receptor AntagonistsIBA 12/2015
1	SaltsIBA 12/2015
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 02/2015
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 02/2015
1	Blood Glucose (Blood Sugar)IBA 08/2012
1	AldosteroneIBA 08/2012
1	Eplerenone (Inspra)FDA LinkGeneric 08/2012
1	Type 1 Angiotensin ReceptorIBA 03/2012
1	CytokinesIBA 03/2012
1	Olmesartan Medoxomil (Votum)FDA Link 03/2012

1	Replantation 02/2015
1	Nephrectomy 03/2012